
Drones targeted a US-linked air base in Kuwait and sites in Bahrain, drawing condemnation from Gulf states a day after Washington struck an Iranian radar installation on Qeshm Island.
The autonomous-drone maker's Series H more than doubles its valuation from March, with proceeds earmarked for an acquisition of radar-sensor maker Echodyne.
The DeepMind spinout's Series C, led by Greenoaks and Sequoia with Andreessen Horowitz joining as a new backer, puts its lifetime fundraising near $7.7 billion as it moves its first AI-designed drugs toward patients.
Oil traders are caught between supply fears from the widening Iran-Gulf conflict and demand worries tied to a hawkish Federal Reserve, leaving Brent stuck in a volatile, directionless range.
Revenue more than doubled year over year under interim CEO Colette Kress, who raised long-term growth guidance even as Wall Street questioned whether AI spending can keep pace.
A multi-institutional study led by the University of Georgia links gaps in critical-care pharmacist coverage, and heavier caseloads, to worse outcomes for intensive-care patients.
Object 2026 ED138, found in Vera Rubin Observatory survey data, could rival Ceres in size — but researchers caution it is still an unconfirmed candidate, not a certified dwarf planet.
Nearly 49 years after launch, the probe crossed the 16-billion-mile threshold this week, a distance so vast that its radio signals now take a full 24 hours to reach mission control.
The combined Warner Bros. Television Studios, launching in early 2027 under executives Channing Dungey and Matt Thunell, is the clearest sign yet of how thoroughly the $110 billion WBD-Paramount merger is reshaping the industry.